betsat bettilt vegabet betkanyon matbet celtabet hilbet melbet kingbetting wipbet pusulabet superbahis lidyabet holiganbet 1xbet asyabahis jetbahis betdoksan betetebet betgram
Michael A den Bakker Author
Subjects of specialization
Affiliation
Langerhans cell histiocytosis
Department of Pathology, Maasstad Hospital, Rotterdam, The Netherlands
Professor in the Department of Pathology, Maasstad Hospital, Rotterdam, The Netherlands, Department of Pathology Erasmus MC, Rotterdam, The Netherlands. Pulmonary Langerhans’ cell histiocytosis (PLCH) presents as accumulation of Langerhans’ cells and other langerin-expressing dendritic cells (LCH cells) in the lungs
Research Article Open Access
Author(s): Michael A den Bakker, Gerard HGK Gathier, Erik Thunnissen, Willem Vreuls, Nils’t Hart, Rosita L ten Berge, Kees Seldenrijk, Robert Jan van Suylen, Anna MJ van Nistelrooij, Francien H van Nederveen, Matyas Bendek , Wim Timens, Nelly Breeuwsma, Mariël Brinkhuis, Hannie Sietsma, Jeroen Stavast, Jan von der Th
Pulmonary Langerhans cell histiocytosis (PLCH) is a smokingrelated condition in which aggregates of Langerhans cells admixed with other inflammatory cells are found in lung tissue. The general view is that PLCH is a reactive condition rather than a neoplasm. However, in small series BRAF c.1799T>A (p.V600E) mutations have been identified which raise the possibility that PLCH may have features of a neoplasm after all. Because the reported cases are few in number, we undertook a multi-institute survey of BRAF mutations in adult smokers. We found BRAF V600E mutations in 57% of our cohort of 61 patients. No significant relation with age or gender and BRAF status was found. Our series confirms the presence of BRAF V600E mutations in a large proportion of PLCH ... view moreĀ»